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A B S T R A C T
The steroidogenic and lipolytic activities of corticotrophin-(l-24)-tetra- 
cosapeptide and [Lys17.18]corticotrophin-(l-18)-octadecapeptide amide 
were compared with those of the corresponding analogues variously sub- 
stituted in position 8 with homo-arginine, ornithine or lysine. Peptides 
substituted with homo-arginine showed a surprisingly high degree of 
biological activity; in all the tests performed, the loss of activity due to 
the substitution did not exceed a factor of 3 to 10, while peptides sub­
stituted with ornithine or lysine in position 8 only showed residual 
biological activity or none at all, depending on the test system used. 
The results reported demonstrated that the presence of a guanidino group 
(arginine or homo-arginine side chain) in position 8 of the ACTH peptide 
is essential for the preservation of a high level of biological activity; the 
length of the aliphatic chain carrying the guanidino group is of minor 
importance.
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In p rev io u s C om m unications (Tesser & Schwyzer 1966; Tesser & Rittel 1969), 
the effect of the substitution of ornithine (cf. formulae, Table 1) for the arginine 
residue in positions 8, 17 and 18 of corticotrophin-(l-24)-tetracosapeptide (I)1 
was described.
It was shown that as far as the biological activity of the peptide is concerned 
the presence of a guanidino group in position 8 is more important than the 
presence of such a group in positions 17 or 18. The need for arginine8 had 
already been demonstrated earlier by Chung 8c Li (1967), who found that the 
biological activity of corticotrophin (1-17) heptadecapeptide amide substituted 
with lysine8 was remarkably weak as compared with that of the peptide con- 
taining arginine8. In addition, according to Geiger (1971) and Schwyzer et al. 
(1971) the active site of corticotrophin is located between positions 5 and 10; 
arginine8 is thus one of the amino acids composing the active centre.
In the present studies, the effect of structural alterations in position 8 on 
steroidogenic and lipolytic activity has been further investigated.
Peptides substituted in position 8 with homo-arginine, ornithine or lysine 
were compared with the unmodified peptide containing arginine.
M A T E R I A L  A N D  M E T H O D S
Peptides. -  The synthesis of the analogues II and VI w ill be described elsewhere 
(Tesser et al., in prep.). Peptide I was prepared according to Kappeler & Schwyzer 
(1961); III was synthesized by Tesser & R itte l (1969). Peptides IV and V were prepared 
by a route analogous to that used in the synthesis of I (Kamber et al., unpublished 
results). The structures of the tested peptides are shown in Table 1.
Steroidogenesis. -  In  vitro, adrenal slices were incubated for 2 h according to the 
method described by Saffran & Schally (1955). The corticosterone content of the 
incubation medium was measured by acid fluorescence (G uïllem in et al. 1959).
In  vivo, the peptides were injected once intravenously into male rats hypophysect- 
omized 24 h previously. The concentration of corticosterone in the plasma was 
determined as described by Desaulles & R itte l (1968).
Lipolysis. -  In the in  vitro  experiments, epididymal fat pads from rats were in­
cubated essentially as described by Jungas & Ball (1963); 4°/o bovine albumin was 
added. After two hours’ incubation the unesterified fatty acids (FFA) released into 
the incubation medium were measured by titration (Dole 1956), and the glycerol 
content estimated as described by W ieland  (1957).
Lipolytic activity in  vivo  was estimated on the basis of the concentration of un­
esterified fatty acids determined colorimetrically in the plasma (Duncom.be 1963),
30 min after the intravenous administration of the peptide.
!) Nomenclature according to the recommendations of the IU P A C -IU B  Commission 
o f Biochemical Nomenclature (1972).
Other abbreviations used: Har = homo-arginine, FFA = unesterified fatty acids, i. e. 
lysine8 = lysine in position 8 of the amino acid sequence.
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Table 1.
Formulae of the corticotrophin peptides tested.
1 2 3 4  5 6 7 8  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
I: H-Ser Tyr Ser Met Glu His Phe Arg 'I'rp Gly Lys Pro Val Gly Lys Lys Arg Arg Pro Val Lys Val Tyr Pro-OH
II: H-Ser Har Arg Arg Pro-OH
III: H-Ser Orn Arg Arg Pro-OH
IV: H-Ser Lys Arg Arg Pro-OH
V: H-Ser Arg Lys Lys n h 2
VI: H-Ser Har Lys Lys n h 2
I: corticotrophin- (1-24) -tetracosapeptide
II: [Har8]corticotrophin-(l-24)-tetracosapeptide
III: [Orn8]corticotrophin-(l-24)-tetracosapeptide
IV: [Lys8] corticotrophin-(l-24)-tetracosapeptide
V: [Lys17.1S] corticotrophin- (1-18) -octadecapeptide amide
VI: [Har8, Lys17>18]corticotrophin-(l-18)-octadecapeptide amide
Animals. -  The experiments were performed on male albino rats of the Sprague- 
Dawley stram (Ivanovas, Kisslegg, Germany) which had been kept on a Standard 
laboratory diet and under controlled lighting conditions. The in  vitro  steroidogenesis 
assays were carried out with adrenals excised from animals weighing 180-200 g. In 
the in  vitro lipolytic assays, epididymal fat from rats weighing 140-160 g was used. 
Rats weighing 180-200 g were selected for the in  vivo  experiments.
Statistical analysis. -  Dose-response curves were constructed from the mean data 
derived from 6 to 10 experiments. Regression lines within the linear part of the 
dose-response curves were calculated by the Hewlett-Packard programme Stat-Pac 
V-6. The relative steroidogenic potencies of the peptides in  vitro  were determined 
in 4-point assays by means of parallel regression analysis (Finney 1964).
R E S U L T S
Steroidogenesis in vitro (Fig. 1, Table 2)
The dose-response regression lines of the two Standard preparations, I and V, 
do not differ significantly, though the latter peptide is slightly more active
pg PE PT IDE/ml
Fig. 1.
In  vitro  steroidogenesis: Dose-response regression lines of corticosterone released from 
rat adrenal slices incubated for 2 h at 37°G. Each point constitutes the mean of 6 to
10 incubations +  s e m .
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Table 2.
In  vitro  steroidogenesis: relative potencies determined in four point assays. 
(adrenal slices of rats incubated for 2 hours).
Standard
compound
Test
compound Potency
Confidence 
limits 95 %>
I II 0.25 0.23 -0.28
I III 0.036* 0.029-0.046
I IV 0.076* 0.061-0.094
0.046* 0.024-0.082
V VI 0.25 0.19 -0.33
0.24 0.20 -0.29
* Owing to significant differences in the slopes of the dose-response curves a valid 
comparison cannot be made.
pg PEPTIDE/m!
Fig. 2.
In  vitro  lipolysis: Dose-response regression lines of FFA released from rat epididymal 
fat pads incubated for 2 h at 37°C. Each point constitutes the mean of 4 to 8 in-
c u b a t i o n s  ±  s e m .
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Table 3.
In  vitro  lipolysis: activities determined by glycerol release (epididymal fat pads of rats).
Test
compound
jug peptide per ml incubation medium
0.001 0.01 0.03 0.1 0.3 1.0 3.0 10
I 0.9 ±  0.2* 8.2 ±  0.6 15.9 ±  0.3 20.7 ±  0.6 - - - -
II - 0.2 ±  0.2 2.7 ±  0.7 9.1 ±  0.8 14.7 ±  1.6 21.2 ±  0.7 -
III - - - - 2.3 ±  0.5 3.8 ±  1.2 10.0 ±  3.5 19.0 ±  1.2
IV - - - - 0.5 ±  0.2 4.7 ± 1.3 9.8 ± 4.0 20.3 ± 4.0
V 1.2 ± 0.5 7.9 ±  0.6 - 20.0 ± 1.5 - - - -
VI - 4.6 ± 1.2 7.1 ± 1.2 15.5 + 0.5 19.1 ± 0.1 20.4 + 1.3 - -
* («Mol glycerol per g fat; each value is the mean of 6-9 incubations.
than the former. The two peptides substituted with H ar8 (II and VI) yield 
dose-response regression lines parallel to those of the respective standards; 
their relative potencies, as determined in 4-point assays, amounts to about 0.25 
of that of the standards (= 1). The two analogues III and IV, substituted with 
Orn8 and Lys8 respectively, are markedly less active. In the 4-point assays they 
differ from the standards in the slope of their dose-response regression lines, 
so that no valid comparison of their potencies can be made. At the semi 
maximal activity level (middle part of the regression lines), their potency in 
relation to that of the respective standards is about 0.04.
Lipolysis in vitro (Fig. 2, Table 3)
The mobilization of unesterified fatty acids (FFA, Fig. 2) and the release 
of glycerol are in good overall agreement with the steroidogenic activity of the 
peptides. The two standards, I and V, show equal activity. The two Har8
T ET RACOSA-PEPTIDES
Fig. 3.
In  vivo  steroidogenesis: Time course of plasma corticosterone concentrations in 24 h 
hypophysectomized rats after a single intravenous injection of the peptides. Each 
point represents the mean of 6 to 12 animals +  s e m .
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peptides, II and VI, also exhibit similar activity. Their dose-response regression 
lines are parallel to those of the Standard com poun ds but a dose 10 times 
higher is necessary to obtain the same lipolytic effect. The two peptides with 
Orn8 or Lyss (III and IV) yielded somewhat steeper dose-response curves than 
the other corticotrophin peptides. When compared at the level of medium effect 
(20 ^Mol/g fat) both peptides proved to be about 300 times less active than 
the Standard compounds. The results obtained by measuring glycerol-release 
are identical to those found by determining FFA mobilization (Table 3).
Steroido gene sis in vivo (Fig. 3)
Steroidogenic activity in vivo was assessed on the basis of the time-response 
curves obtained after the intravenous administration of single doses of 3 and 
30 figfkg of each of the peptides.
At these dose levels, the maximum corticosterone concentrations produced 
by the 4 peptides tested (I, II, V and VI; III and IV were not assayed) do not
TETRACOSA-PEPTIDES OCTADECA-PEPTIDES
M9 P E P T iD E /kg  BODY WEIGHT
Fig. 4.
In  vivo  lipolysis: Dose-response regression lines of plasma FFA concentrations in 
intact rats 30 min after a single intravenous injection of the peptides. Each point 
represents the mean of 14-21 animals +  s e m . Basal values (132 ±  12) of 50 rats in- 
jected with saline only are shown as shaded area.
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differ significantly, but the duration of their steroidogenic effects varies. The 
two Standard peptides have an almost identical duration of action, the 10 fold 
dose eliciting an almost doubly prolonged effect. The [Har8] tetracosapeptide
(II) has a shorter duration of effect than the standards, I and V ; a dose roughly 
three times greater than that of the Standard peptide I would have to be given 
to achieve the same duration of effect. The [Har8, Lys17’18]octadecapeptide (VI) 
does not differ significantly from the two standards.
Lipolysis in vivo (Fig. 4)
The slopes of the dose-response regression lines of the four active peptides 
are parallel. The Standard compounds, I and V, and [Har8, Lys17’18] octadeca- 
peptide (VI) display identical activity, whereas the [Har8] tetracosapeptide (II) 
is only half as potent. The two tetracosapeptides, III and IV, with Orn8 and 
Lys8 show no lipolytic activity up to the highest dose tested (1 mg/kg).
D I S C U S S I O N
The biological importance of arginine in position 8 of corticotrophin peptides 
has been investigated. Replacement of arginine by homo-arginine (Fig. 5) 
results in only a slight reduction in the steroidogenic and lipolytic activity of 
the peptides, while the substitution of ornithine or lysine drastically diminishes 
these effects.
The four analogues differ as regards not only the pKa of the basic group 
in position 8 (guanidino-group pKa 12.5, amino group pKa 10.5), but also the 
length of the aliphatic chain which carries the basic grouping. Our results 
clearly demonstrate the eminent importance of the guanidino group, while 
the length of the aliphatic chain is obviously of minor significance, the bio­
logical activity of the homo-arginine analogues being only slightly reduced.
h2 Nn ,NH Ci
H2N, ,nh 
c
NH NHp | cNHI ch2 NH, i £ CH2CH2l ch2
C\JIO- ch2
CHo l c- ch2 CH2 ch2ch2 1 c- CHo i £ ch2 ch2-NH-CH-CO- -NH-CH-CO- -NH-CH-CO- -NH-CH-CO
Ar g H a r Or n Lys
Fig. 5.
Chemical structures of the amino acids arginine (Arg), homoarginine (Har), 
ornithine (Orn) and lysine (Lys).
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These findings confirm and add precision to the results of earlier investiga- 
tions (Tesser 8c Schwyzer 1966; Tesser 8c Rittel 1969) indicating the importance 
of arginine8. It has been shown that the arginyl residues in position 17 and 18 
are not indispensable as regards biological activity; they can be replaced by 
ornithine (Tesser 8c Schwyzer 1966) or by lysine (Desaulles et al. 1969) without 
substantially altering the effects of the peptides. The 11-24 region of corti- 
cotrophin is assumed to be essential to the binding of the peptide to its cell- 
membrane receptor, but is less important, if at all, for the stimulation of the 
receptor (Hofmann et al. 1970; Schwyzer et al. 1971; Finn et al. 1972). On 
the other hand, the 5-10 region is considered to represent the stimulating 
locus of corticotrophin. This diversity of function might explain the unequal 
importance of the arginyl residue in position 8 as compared with positions 17 
and 18. To stimulate the receptor, a guanidino group is a necessity, while an 
amino group appears to be inadequate; in the binding region (17/18), however, 
either of the basic residues sufficies. It is tempting to believe that the receptor 
can discriminate between two groups whose base strengths differ by a factor 
of 100. Although this difference is most conspicuous, it is reasonable to assume 
that both residues are completely protonated in aqueous solution under physio- 
logical conditions prevailing in the serum or plasma.
It is therefore anticipated, that a protonated guanidino group in position 8 
also occurs when the peptide is in intimate contact with the receptor site. The 
inadequacy of the ammonium group to stimulate the true receptor site mighl 
be attributed to the small spatial extent of its positive charge in contradistinc-
Table 4. 
Approximate potencies.
Test
compound
Steroidogenesis Lipolysis
in  vitro in vivo in vitro in vivo
I» 1 1 1 1
II 0.25 0.3 0.1 0.5
III 0.06 - 0.003 0 !f!f
IV 0.04 - 0.003 0 * *
V 1 1 1 1
VI 0.25 1 0.1 l
'* Activity was arbitrarily set at 1.
** Inactive up to a dose of 1 mg/kg iv.
A c t a  e n d o c r . 74 , 1
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5
tion to the larger resonance-stabilized guanidinium group. The latter, moreover, 
affords the possibility of interaction with some bidentate structure in the re­
ceptor site by way of a hydrogen bond, additional to its electrostatic bond.
The steroidogenic and the lipolytic potencies of the peptides investigated in 
this study are indicated in Table 4. It is evident that the relative activities 
of the tested corticotrophins are highly similar in the two in vitro test systems. 
It may therefore be speculated that the corticotrophin receptors of the adrenal 
and the fat cell are similar in structure.
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A NOVEL PHOTOCYCLIZATION, STARTING FROM
1,4-EIARYLBUTENYNES
A.H.A. Tinnemans and W.H. Laarhoven
Department of Org-anic Chemistry, Catholic University, 
Toernooiveld, Nijmegen, The Netherlands 
(Reoeived in UK 25 January 1973> aaeepted for publication 1 February 1973)
Cis-trans isomerization is the only known photochemical reaction of aryl- 
butenynes^ until now. We found, however, that irradiation under nitrogen of a 
dry and deaerated solution (ü>.10-^ molar) of 1- £*-naphthyl)-4-phenylbut-1-en- 
3-yn (I) in benzene with a '360 urn fluorescence lamp (Sylvania blacklite P8T5) 
during four hours converted the solute into 1-phenylphenanthrene (Ila), 45$.
Although no oxidation step is involved the cyclization is slightly faster 
in the presence of air; in a solution saturatüd with oxygen or supplied with a 
small amount of iodine (3-10-'’ molar) the rate is about twice as faat as in a 
deaerated and iodine-free solution.
The main irradiation product in a deaerated solution of I eontaining an 
equiraolar amount of iodine is an iodo darivative, 1-phenyl-2-iodophenanthrene 
(Ila). On prolonged irradiation of this solution iodine is replaced by a phe- 
nyl group^, giving rise to an increasing amount of 1,2-diphenylphenanthrene 
(IIc, m.p. 151°).
Q
IIc (about 5-fi)
benzene solution 
o
The cyclization is a light-induced reaction. Hefluxing a
of I in the dark or heating of pure I in an evacuated tube at 300 during four
hours did not yield any cyclization product.
Irradiation under nitrogen of an iodine-free solution of I (5.10“^ molar)
in hexane in the presence of triplet-sensitizers like 2-methylanthraquinone,
— Pbenzophenone, benzil or acetophenone (0-1.2.10“ molar) did not lead to higher 
yields of Ila. Also the presence of the triplet-quencher azulene did not in- 
fluence the result of the photoreaction.
817
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The radical scavenger di-tert.butylnitroxide^ (10~^-4.10-  ^molar) had no 
influence upon the cyclization of I into Ila. However, on irradiation a solu- 
tion of I containing iodine as well as this radical scavenger only Ila and 
not Ilb and IIc was formed.
From these results it may be concluded that Ila arises from a singlet 
excited state of I. It is known that acetylenes in the first excited state
5have non-linear trans configurations , which should be very favourable for the 
ring-closure observed. The formation of the new C-C bond and the 1 ,5-h,ydrogen 
shift rnay be a concerted. ' In the presence of iodine cyclization pro­
duct Ilb is apparently formed via a radical intermediate, possibly formed by 
the addition of an iodine atom to the triple bond of I.
The new photocyclization raction has been investigated on several other 
diarylbutenynes (Table).
Table
2Irradiation products from diarylbutenynes , 
Ar1-CH=CI-I-C=C-Ar2
without iodine________ with iodine
Ar1 Ar2 pro­
duct
yield m.p.°C pro­
duct
yield
cp
0„ ' m.p. C
1£X-naphtyl phenyl Ila 45 74-76 Ilb 50 166-168
2 phenyl phenyl - -
3 p. methoxyphenyl phenyl -
4 3»5-dimethylphenyl phenyl Illa 44 liquid x )
5 A-naphthyl phenyl IVa 55 82-84 IVb 44 160-162
6 «-(4-methylnaphthyl) phenyl lid 54 89-92 Ile 19 93-95
7 /3-(8-phenylnaphthyl) phenyl IVc 65 169-171 IVd 16 135-140
8 3-phenanthryl phenyl Va 50 109-113 Vb 32 131-133
9 2-benzo c phenanthryl phenyl -
0 9-(1-phenylphenanthryl ) phenyl Vla 60 150-152 VIb 44 254-260
1 phenyl «-naphthyl -
"*)2 «-naphthyl «-naphthyl Vila 22 116-118
3 /2> -naphthyl o<-naphthyl Villa 38 150-152 VlIIb 38 137-140
s ) Irradiation had to be carried out with a high pressure mercury lamp in
hexane; under these circumstances carbon-iodine bonds are broken.
Only a mixture of dimers had been formed.)
No. 11 819
Ha: R1 = R2 = H lila IVa: R1 I
I w ru = H
b: R1 =  I, IIc\
O
h H b: R1 = i, R2 =
c : R1
O
II H R, = H c : R1 = H, r 2 =
d: R1 = H, r2 = c h3 d: R1 = I, R2 =
e : R 1 =  I, R2 = CH3
Va: R = H 
b: R = I
Vla: R = H 
b: R = I
VI Ia Villa: R = H 
b: R = I
820 No. U
The negative results in the experiments 2, 3 and 11 compared with the cycliza-
tion in 4 suggest that some factor related to the electron-distribution in the
relevant ring is of decisive importance for the cyclization. The failure of cy-
clization in experiment 9 may be due to the strong tendency of the starting
compound to dimerization, even in dilute solutions. In all other cases only one
type of cyclization product was obtained; bond forination occurs always between
an aoetylenic carbon (C^ in I) and the aromatic ring at . In this respect the
reaction is clearly different from photocyclizations in diarylbutadienes^,
which lead to two products if different arylresidues are present in the star- 
7ting compound . The experiments 7, 8 and 10 reveal that even highly crowded 
polycyclic aromatics can be obtained quite specifically and in good yields from 
properly chosen diarylbutenynes.
Pull experimental details concerning the syntheses and spectroscopie data 
and properties of the products will be given elsewhere.
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1. Introduction
In previous Communications, we [1] described the 
use of Sepharose-linked binding proteins for a con- 
venient and precise assay of cyclo-3',5'-adenosine 
monophosphate (cAMP) according to the principle of 
competitive protein binding (CPB) between unlabelled 
and labelled cAMP. The method had the advantage 
of allowing a simple and rapid separation óf “bound” 
from “free” radioactive cAMP by mere filtration of 
the “immobilized” protein linked to the Sepharose.
It avoided all the difficulties arising with soluble 
cAMP binding proteins that had been in use hitherto 
(for references see [1]).
It occurred to us that similar improvements could 
possibly be achieved for the CPB assays of plasma 
testosterone. In a collaborative effort, we succeeded 
in devising an equally convenient and precise testo­
sterone assay using Sepharose-linked testosterone 
binding proteins from human late pregnancy serum.
2. Materials and methods
Water was deionized and twice distilled before use. 
For measuring aqueous solutions, we used Oxford, for 
solutions in organic solvents, glass pipettes. Buffer I:
0.1 N NaHC03/0.1 N NaCl; buffer II: 0.05 M Tris- 
HC1, pH 7.4.
2.1. Sepharose-linked testosterone binding proteins
3 g of Sepharose activated with cyanogen bromide 
(purchased from Pharmacia or prepared according to 
[1]) were suspended in 10 ml of buffer I and kept 
for 20 min at room temp. The gel was transferred to 
a porous glass filtration funnel and washed for not 
more than 15 min with approx. 200 ml of 0.001 N 
HC1 to remove soluble impurities. The material on the 
filter was then washed with approx. 200 ml of buffer
I, sucked almost dry, and transferred to a solution of 
2 ml of human late pregnancy serum (third trimester) 
in 5 ml of buffer I contained in a 100 ml round bot- 
tomed flask. The mixture was gently stirred by slow 
rotation of the flask at 4° for 15 hr. The protein- 
modified Sepharose was collected on a porous glass 
filter and washed with 250—500 ml of buffer I, fol- 
lowed by 250—500 ml of buffer II. The gel was then 
suspended in 200 ml of buffer II and stored until 
used at approx. 1—4P in a beaker sealed with “Para- 
film” .
2.2. Assay o f  "testosterone-like substances” in blood 
plasma
2.2.1. Preparation of plasma extracts and blanks
The heparinized blood was immediately centrifuged 
and the plasma stored at —20° in plastic vials. 1.0 ml 
of the plasma (or a smaller amount diluted to 1.0 ml 
with water) was placed, together with 5.0 ml of 
spectroscopie grade dichloromethane, into a glass-
North-Holland Publishing Company -  Amsterdam 127
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stoppered vial and agitated for 1 min. The aqueous 
phase was pipetted off and replaced with 0.5 ml 1 N 
Na2C 03 solution. After agitation (30 sec) and centri- 
fugation, the aqueous phase was removed, and the 
organic phase washed neutral with two to three 
successive 0.75 ml volumes of water (test with pH 
paper). Four 0.50 ml aliquots of the organic phase 
were pipetted into four Eppendorf vials and kept in 
a vacuum desiccator for at least 1 hr at approx. 10 Torr. 
For the estimation of blank values, 1.0 ml of water 
was treated in exactly the same manner as the plasma 
samples.
2.2.2. Calibration
For every assay (double estimations of the 
unknowns) a calibration curve was constructed, using 
50 t±\ each of ethanolic solutions containing in this 
volume 5.0, 1.25, 0.32, 0.008, and zero ng of 
testosterone in Eppendorf vials. The solvent was 
removed as in sect. 2.2.1.
2.2.3. Binding assay
100 fi\ of [ 1,2-3H] testosterone (Amersham) in 
water (=10 nCi) were added to each of the desiccated 
vials (mechanical shaking for 30 sec dissolved the 
dried extract or blank). The protein-modified Sephar- 
ose in the storage beaker was evenly suspended by 
slow magnetic stirring, and 200 fi\ each of the 
suspension pipetted into the vials. After mechanical 
agitation for 5 sec, equilibration was achieved by 
standing at room temp. for unspecified times between 
20 and 120 min. The contents of the vials were then 
pipetted onto 35 /jm polyester nets (Müllereigaze Estal 
mono PE 35, No. 19176, Schweizerische Seidegaze- 
fabrik AG., Thai, Switzerland) contained in suction 
filter funnels. The vials were rinsed with 1 ml each of 
buffer II, and the materials on the filters washed once 
or twice with approx. 1 ml of the same buffer 
(volumes aren’t critical). The nets were transferred 
into the counting vials and covered with 5 ml of the 
scintillant solution (Insta-Gel, Packard). After agita­
tion, the radioactivity was determined by scintillation 
counting (Packard Tri-Carb instrument). It was usually 
expressed in percentage of a 100% value (= 100 ;ul of 
the above [1,2-3H] testosterone solution added to the 
scintillant).
3. Results
3.1. Properties o f  the “Sepharose-linked testosterone 
binding pro teins”
The mean association constant for [ 1,2-3H] testo­
sterone in 33 mM Tris-HCl buffer, pH 7.4, at 20°, and 
the Hill coefficients, n, were determined according to 
the method described in [1]: ^ ass = 9.87 X 108 1/mole 
(^diss= 1-01 X10-9 mole/1); n = 1. The non-specific 
adsorption of [ 1,2-3H]testosterone to Sepharose and 
to the polyester net is less than 1% of the total tracer 
concentration added.
3.2. Water blank
The water blank is considerably lower with the 
present method (x = 6.8 ng/100 ml, = 2.2, n = 5) 
than with Florisil 2 (x = 64.6 ng/100 ml, = 4.6, 
n = 13). In both cases, the extraction was carried out 
with dichloromethane, the solvent giving the lowest 
“reagent blank” [3],
3.3. Plasma testosterone values
Results obtained with the present method from 
samples of normal subjects and patients with various
Tabie 1
Plasma testosterone values in normal pubertal and adult males.
Subject No. Age
(yr)
Plasma 
testosterone 
(ng/100 ml)
1 15 644
2 16 680
3 16 685
4 17 410
1000*
1025*
1300*
5 17 465
6 17 470
7 19 530
8 20 800
9 21 455
10 54 980
Mean value ± s 6 1 2 ± 172
* = 2, 4 and 6 days after administration of human chorionic 
gonadoptropin (5000 U per square meter of body surface area).
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Table 2
Plasma testosterone values in patients with various disorders.
Subject No. Age
(yr)
Sex Diagnosis
Plasma 
testosterone 
(ng/100 ml)
High values
1 3 M Idiopathic precocious 
puberty, untreated 750
2 6 M Idiopathic precious 
puberty untreated
Under treatment with 
cyproterone acetate
1140
410
3 19 M Testicular teratoma, 
untreated
After surgery
600
235
4 23 F Idiopathic hirsutism 210
5 23 F Idiopathic hirsutism 380
6 30 F Idiopathic hirsutism 450
7 27 M Congenital adrenal 
hyperplasia (21-hydroxyl- 
ase deficiency), untreated 1265
8 30 F Virilizing adenoma of the 
left adrenal:
Left adrenal venous plasma 
Right adrenal venous plasma
6500
1600
Low values
9 0.6 M Tall stature within normal limits 33
10 4 M Hereditary defect of testosterone 
biosynthesis (17,20-desmolase 
deficiency)
20
11 6 M Congenital anorchia 10
12 52 M Castrate, untreated 25
13 16 M Delayed puberty 105
14 16 M Delayed puberty 210
15 17 M Delayed puberty 260
16 17 M Delayed puberty 345
17 18 M Delayed puberty 130
18 19 M Delayed puberty 171
19 17 M Klinefelter’s syndrome 165
20 35 M Hypogonadism 120
21 40 M Hypogonadism 175
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endocrine disorders are displayed in tables 1 and 2.
They agree well with those reported by others using 
different techniques [4, 5], The mean value obtained 
in normal pubertal and adult males was 612 ± 172 
ng/100 ml (m=10), while a compiled average from the 
literature [5] is 670 ± 230 ng/100 ml. The highest 
figure was obtained for adrenal venous blood from a 
patiënt with virilizing adrenal adenoma (6500 ng/100 
ml, patiënt No. 8, table 2). High values were also 
found in untreated patients suffering from congential 
adrenal hyperplasia due to a 21-hydroxylase deficiency 
and from idiopathic precocious puberty. In the latter 
condition, there was, in one case studied, a definite 
reduction of the level during treatment with cypro- 
terone acetate. Low values were obtained in an adult, 
unsubstituted castrate male, in a boy with congenital 
anorchia, and in one child with a congenital defect of 
testosterone biosynthesis (17,20-desmolase deficiency, 
proven by incubation of testicular tissue with testo­
sterone precursors [6]). Moderately low levels were 
found in cases with benign delayed puberty, Klinefelter’s 
syndrome, and hypogonadism, as one would expect.
4. Discussion
The competitive protein binding technique for the 
assay of hormones in biological fluids was introduced 
by Ekins (1960) for thyroxin [7]. Subsequently,
Murphy [8, 9] adapted the principle for the estimation 
of steroids. A large number of methods for the deter- 
mination of various steroids using CPB has since been 
published (for references and discussion see [10].
These techniques have the advantage of relative sim- 
plicity and high sensitivity. Their specificity, however, 
depends on the prepurification steps applied rather 
than on the CPB itself.
Among other difficulties, one of the major problems 
of CPB techniques is the separation of the free from 
the protein bound steroid fraction. For this purpose, 
various methods have been used, including gel filtra- 
tion (Sephadex G25 [11], dextrane coated charcoal
[12], ammonium sulfate for protein precipitation
[13], and Florisil, p.e. [2, 14, 15]). We have, in the 
Dept. of Pediatrics, been previously using a modifica- 
tion of the relatively simple and non-specific method 
of Anderson [2] for the determination of “testoster- 
one-like” substances in plasma, where no prepurifica­
tion is carried out and the separation of the free from 
the bound fraction is done with Florisil. Our modifi- 
cations consisted of. extraction with methylene 
chloride instead of ether (lower non-specific “reagent” 
blank, cf. [3]), of a different CPB step, cf. [16], and 
of minor changes of shaking.
Although for clinical use, the results obtained with 
this previous method agreed well with those of urinary 
steroid determinations in the same subjects by highly 
specific gas chromatographic techniques (Zachmann 
[17]), the separation step with Florisil was a constant 
source of difficulties and did impair the reproducibili- 
ty of the calibration curves due to its sensitivity to 
even minimal changes of shaking time and other 
methodological factors. In addition, in our experience 
and in that of others [9, 15], too high testosterone 
values were obtained with Florisil in plasma samples 
from prepubertal children and females, and the water 
blanks were relatively high.
Similar difficulties had been encountered in the 
CPB assays of cAMP and had been overcome by the 
use of relatively very stable, Sepharose-linked cAMP 
binding proteins [1], The results presented in this 
paper show that analogous improvements can be 
achieved for steroid assays with the help. of immobil- 
ized binding proteins. The advantages cohsist in: 
i) rapid and facile separation of bound and free steroid 
fractions by simple filtration, ii) the constant equilib- 
rium between 20 min and at least 3 hr, resulting in 
improved reproducibility of the Standard curves and 
relative insensitivity to changes in handling times, 
iii) reduction of the water blank, iv) no observable 
desorption of testosterone during filtration and 
washing procedures, v) the negligible nonspecific 
adsorption of testosterone to Sepharose and polyester 
net, and vi) the stability of the Sepharose-linked 
protein.
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